Mounjaro (tirzepatide), is MHRA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions like hypertension. Clinical trials (e.g., SURMOUNT-1) show 20–22.5% average weight loss over 72 weeks.  It’s safe when prescribed by a UK clinician and monitored.

Mounjaro targets both GLP-1 and GIP receptors, outperforming Wegovy (semaglutide) and Saxenda (liraglutide), which target only GLP-1. Trials show Mounjaro achieves 20–22.5% weight loss over 72 weeks, compared to 15% for Wegovy and 5–10% for Saxenda. Side effects (e.g., nausea) are similar, but Mounjaro has less long-term UK safety data. We can advise on the best choice for you.

Mounjaro is suitable for UK adults with a BMI ≥30 or ≥27 with weight-related conditions, combined with diet and exercise. It’s effective but carries risks like gastrointestinal side effects or, rarely, pancreatitis. A UK clinician must assess your health to confirm it’s appropriate, especially for those without other medical conditions.

Buying Mounjaro from unregulated online sources risks counterfeit or unsafe products. Reputable UK online pharmacies like Pharma Valley require a review & medical consultation. You can verify our pharmacy is registered with the General Pharmaceutical Council (GPhC). It is advised to ensure a reputable source to avoid scams.

Common side effects (nausea, diarrhoea, constipation) are usually mild and subside over weeks, especially with gradual dose increases. However, they may affect daily activities initially. Rare serious side effects, like pancreatitis, require urgent medical attention. Discuss potential impacts with our clinicians to balance benefits and risks.

Mounjaro delivers 20.9% average weight loss over 72 weeks with diet and exercise, compared to 3.1% for lifestyle changes alone (placebo group in trials). Non-medication methods, like apps (e.g., WeightWatchers) or gym programmes, yield slower, less significant results. Mounjaro requires ongoing use for sustained effects.

UK reviews report 9–17 kg weight loss and improved confidence, but reviews can be biased or fake. Social media posts may exaggerate results. Verify claims with clinical trial data and consult our clinicians to avoid misinformation. On our site we only use data from highly regarded trials and authentic review.

Mounjaro may interact with certain medications, like oral contraceptives, reducing their effectiveness, or worsen conditions like severe gastrointestinal disorders. It’s not recommended for those with a history of thyroid cancer or pancreatitis. Our UK clinicians will review your medical history to ensure safety.

Mounjaro requires ongoing use with diet and exercise for sustained weight loss. Studies show weight regain is likely after stopping without lifestyle maintenance. Consider the long-term commitment (costs ~£128–£245/month via UK pharmacies) before starting. Our clinicians can help plan for sustainability.